Telefonica teamed with healthcare R&D organisation Fundacion Vithas and Francisco de Vitoria University on a project to utilize quantum computing to aid creation of cancer drugs, work set to be discussed during MWC26 Barcelona next month.
The operator explained the project utilizes a hybrid model of classical and quantum computing to design molecules which inhibit a mutation responsible for a range of malignant tumours.
“Quantum computing allows for much more efficient exploration of chemical combinations that would take years to generate applying traditional computing, thus reducing research times,” it added.
Telefonica Spain head of applied quantum projects Juan Cambeiro noted the “initiative demonstrates how quantum computing has relocated beyond theory to become a tool with real possibilities in sectors such as healthcare, industest, logistics and banking”.
Subscribe to our newsletter
Get breaking news, exclusive insight, and expert analysis – before anyone else.
“By combining traditional machine learning techniques with quantum circuits in this project, we are not only reducing research times, but also opening the door to more efficient and accessible medicine.”
Information on the project will be available on the Telefonica stand at MWC26 Barcelona, which starts on 2 March, with a roundtable scheduled during the event for an in-depth view at the project.
Fundacion Vithas is part of private healthcare company Vithas hospital group, which Telefonica demonstrated work with at MWC25 Barcelona related to a project on utilize of quantum key distribution for data security.
Leave a Reply